John V Crues

CIK 1274197 · View on SEC EDGAR ↗

Insider

First SEC filing: Jan. 13, 2016 · Latest: Jan. 13, 2016

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 24 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

24 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
June 5, 2015 RDNT S 2,500 $6.66 $16,650 778,112 Direct -0.32% Disposed 1042.8% (price as of 2026-08-20)
June 5, 2015 RDNT S 2,500 $6.61 $16,525 780,612 Direct -0.32% Disposed 1051.4% (price as of 2026-08-20)
June 5, 2015 RDNT S 5,000 $6.60 $33,000 783,112 Direct -0.63% Disposed 1053.2% (price as of 2026-08-20)
June 3, 2015 RDNT S 10,000 $6.49 $64,900 778,112 Direct -1.27% Disposed 1072.7% (price as of 2026-08-20)
June 2, 2015 RDNT S 5,000 $6.44 $32,200 788,112 Direct -0.63% Disposed 1081.8% (price as of 2026-08-20)
Aug. 18, 2014 RDNT S 16,667 $6.91 $115,169 768,112 Direct -2.12% Disposed 1001.4% (price as of 2026-08-20)
May 13, 2014 RDNT S 16,667 $6.40 $106,669 784,779 Direct -2.08% Disposed 1089.2% (price as of 2026-08-20)
May 13, 2010 RDNT S 50,000 $3.34 $167,000 578,708 Direct -7.95% Disposed 2178.7% (price as of 2026-08-20)
Jan. 10, 2008 RDNT S 10,000 $9.51 $95,100 423,262 Direct +2.42% Acquired 700.3% (price as of 2026-08-20)
Dec. 4, 2007 RDNT S 11,000 $9.29 $102,190 770,719 Direct +1.45% Acquired 719.3% (price as of 2026-08-20)
Sept. 11, 2006 RDNT S 20,900 $2.60 $54,340 471,375 Direct -4.25% Disposed 1363.7% (price as of 2026-08-20)
July 17, 2006 RDNT S 1,600 $1.60 $2,560 492,275 Direct -0.32% Disposed 2278.4% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
April 14, 2014 RDNT Stock Option Common Stock (100,000) $2.40 June 15, 2014 100,000 Disposed
April 26, 2010 RDNT Warrant Common Stock (250,000) $0.72 June 7, 2010 250,000 Disposed
June 15, 2009 RDNT Stock Option Common Stock (100,000) $2.40 June 15, 2014 100,000 Acquired
April 5, 2007 RDNT Warrant Common Stock (150,000) $0.92 Dec. 18, 2008 150,000 Disposed
Sept. 21, 2006 RDNT Warrant Common Stock (200,000) $0.46 Dec. 18, 2008 200,000 Disposed
Sept. 21, 2006 RDNT Warrant Common Stock (200,000) $0.46 Dec. 18, 2008 200,000 Disposed
June 7, 2005 RDNT Warrant Common Stock (500,000) $0.36 June 7, 2010 500,000 Acquired
Dec. 18, 2003 RDNT Warrant Common Stock (500,000) $0.46 Dec. 18, 2008 500,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

RDNT

III, M.D., Vice President and Medical Director
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2010 $549,870 — — — — — $6,000 —
2009 $590,613 — — $146,516 — — — —

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.